Werewolf Therapeutics, Inc.
SEC CIK 1785530 · HOWL · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Evnin Luke | Director | filed 2021 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2021 - 2026 |
| RA Capital Management, LLC | Director | filed 2021 - 2026 |
| Kolchinsky Peter | Director | filed 2021 - 2026 |
| Shah Rajeev M. | Director | filed 2021 - 2026 |
| Sherman Michael A. | Director | filed 2021 - 2025 |
| Morrison Briggs | Director | filed 2021 - 2025 |
| Lazarus Alon | Director | filed 2021 - 2025 |
| Chatterjee Meeta | Director | filed 2021 - 2025 |
| Singhal Anil K. | Director | filed 2025 - 2025 |
| Atkins Michael B. | Director | filed 2024 - 2025 |
| RA Capital Nexus Fund II, L.P. | Director | filed 2024 - 2025 |
| Hicklin Daniel J | Director · See Remarks | filed 2021 - 2025 |
| Dirocco Derek | Director | filed 2021 - 2024 |
| Asanuma Sakae | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Urban Michael J. | VP of Finance & Corp. Contr. | filed 2026 - 2026 |
| Bloom Steven H. | Chief Business Officer | filed 2025 - 2025 |
| Trost Timothy W. | Chief Financial Officer | filed 2021 - 2025 |
| Isaacs Randi | Chief Medical Officer | filed 2021 - 2025 |
| Lubman Ellen | Chief Business Officer | filed 2021 - 2025 |
| Karunatilake Chulani | Chief Technology Officer | filed 2021 - 2025 |
| Seidel-Dugan Cynthia | Chief Scientific Officer | filed 2021 - 2024 |
| Leonard Reid | Chief Operating Officer | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.